Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jupiter Neurosciences (JUNS) Notes Payables (2024 - 2025)

Jupiter Neurosciences (JUNS) has disclosed Notes Payables for 2 consecutive years, with $5.3 million as the latest value for Q4 2025.

  • Quarterly Notes Payables rose 3518.11% to $5.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.3 million through Dec 2025, up 3518.11% year-over-year, with the annual reading at $5.3 million for FY2025, 3518.11% up from the prior year.
  • Notes Payables for Q4 2025 was $5.3 million at Jupiter Neurosciences, up from $146432.0 in the prior quarter.
  • The five-year high for Notes Payables was $5.3 million in Q4 2025, with the low at $146432.0 in Q4 2024.